Meeting Objectives
Explore current knowledge of exposure-response relationships for approved antiretrovirals
Explore role and limitations of this data in evaluating new formulations and regimens
Discuss amount, duration, and circumstances when clinical data are necessary
Discuss implications for special populations
Create basis for Industry Guidance